Sun Pharma Q3FY26 Net Profit Up By 16% At Rs 3,368.8 Crore
The company’s board has declared an interim dividend of Rs 11 per equity share of Rs 1 each for FY26.
The company’s board has declared an interim dividend of Rs 11 per equity share of Rs 1 each for FY26.
The company's revenue from operations rose by more than 16% annually to Rs 21,847 crore, while its operating margins improved to 12.60% in Q3FY26 compared to 12.07% in Q3FY25.
Consolidated revenue from operations fell by 8.9% to Rs 12,451 crore year-on-year (Y-o-Y) from Rs 13,671 crore and on a sequential basis, revenue dropped 7.5% from Rs 13,456.84 crore.
On a quarter-over-quarter (QoQ) basis, net profit rose by 47.8 per cent from Rs 2,649 Crores in Q2 FY26 to Rs 3,916 crores in Q3 FY26.
The company reported a robust turnaround in its Q2FY26 performance, driven by higher volumes, improved operational efficiency and reduced finance costs, according to its official statement.
Coal India reported a 17 per cent drop in consolidated net profit to Rs 8,505.57 crore for the third quarter (Q3) of the financial year 2024-25 (FY25).
The market capitalisation of CPSEs more than doubled in Fiscal Year 2024-25 as compared to Fiscal Year 2023-24, the report said.
State Bank of India (SBI) on Friday reported 28 per cent spike in net profit at Rs 18,331 crore for the quarter ended September 30, 2024. In the year ago period, it reported net profit of Rs 14,330 crore. On a sequential basis, SBI's Q2 profit rose 7.6 per cent from Rs 17,035.16 crore.
The company broke all previous records and achieved an unprecedented milestone by crossing operational income of Rs 10,400 crore.
With this growth, the company's consolidated net profit spiked to Rs 12,434 crore, compared to Rs 11,392 crore for the corresponding quarter of the previous year.
